Moneycontrol
HomeNewsBusinessEconomy'The stakes couldn't be higher': EU recovery plan summit under way

'The stakes couldn't be higher': EU recovery plan summit under way

The 27 leaders, all masked up, greeted each other with elbow bumps rather than their customary cheek kisses and handshakes, and there were birthday gifts for German Chancellor Angela Merkel and Portuguese Prime Minister Antonio Costa.

July 17, 2020 / 16:35 IST
Story continues below Advertisement

European Union leaders met on Friday for tense summit talks on a multi-billion-euro plan to breathe life into their economies, their first face-to-face meeting since the coronavirus pandemic plunged the bloc into its latest crisis.

The 27 leaders, all masked up, greeted each other with elbow bumps rather than their customary cheek kisses and handshakes, and there were birthday gifts for German Chancellor Angela Merkel and Portuguese Prime Minister Antonio Costa.

Story continues below Advertisement

But their display of bonhomie came after weeks of cross-continent quarrelling over the scale and scope of a joint rescue fund. As Merkel went into the talks, due to last two days, she warned that a deal was far from certain.

"I must say that the differences are still very, very big," she said. "I expect very, very difficult negotiations."

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show